Cargando…

CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome

BACKGROUND: CHA2DS2-VASc score, used for atrial fibrillation to assess the risk of embolic complications, have shown to predict adverse clinical outcomes in acute coronary syndrome (ACS), irrespective of atrial fibrillation. This study envisaged to assess the predictive role of CHA2DS2-VASc score fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Abhay Kumar, Pathak, Vijay, Kunal, Shekhar, Shukla, Shubhra, Pathak, Pooja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890954/ https://www.ncbi.nlm.nih.gov/pubmed/31779857 http://dx.doi.org/10.1016/j.ihj.2019.09.005

Ejemplares similares

CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention
por: Mirbolouk, Fardin, et al.
Publicado: (2018)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score as predictor of ischemic stroke in patients undergoing coronary artery bypass grafting and percutaneous coronary intervention
por: Tian, Yaohua, et al.
Publicado: (2017)

Predictive value of CHA(2)DS(2)VASC score for contrast-induced nephropathy after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction
por: Samir, Ahmad, et al.
Publicado: (2023)

Modified CHA(2)DS(2)-VASc score predicts in-hospital mortality and procedural complications in acute coronary syndrome treated with percutaneous coronary intervention
por: Abugroun, Ashraf, et al.
Publicado: (2020)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Guo, Tingting, et al.
Publicado: (2021)

CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience
por: Wang, Yong, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

Prognostic value of CHADS(2) and CHA(2)DS(2)-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Ma, Xiaoteng, et al.
Publicado: (2020)

Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation?
por: Ahmed, Ammar, et al.
Publicado: (2021)

Risk stratification using the CHA(2)DS(2)-VASc score in patients with coronary heart disease undergoing percutaneous coronary intervention; sub-analysis of SHINANO registry()
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention After Risk Stratification With the CHA(2)DS(2)-VASc Score
por: Na, Kun, et al.
Publicado: (2022)

The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery
por: Tasbulak, Omer, et al.
Publicado: (2022)

Predictive value of CHA2DS2-VASc score in radial artery occlusion after transradial coronary angiography
por: Nadir, Aydın, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
por: ZHENG, Jian-Yong, et al.
Publicado: (2022)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions
por: Kumar, Rajesh, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

The Validation of the ATRIA and CHA2DS2-Vasc Scores in Predicting Atrial Fibrillation after Coronary Artery Bypass Surgery
por: Uysal, Dinçer, et al.
Publicado: (2020)

Assessment of the CHA(2)DS(2)-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2021)

CHA(2) DS(2) -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization
por: Shaikh, Abdul Hakeem, et al.
Publicado: (2022)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

Does CHA(2)DS(2)-VASc Score Predict MACE in Patients Undergoing Isolated Coronary Artery Bypass Grafting Surgery?
por: Kalyoncuoglu, Muhsin, et al.
Publicado: (2019)

Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
por: Wu, Yaxin, et al.
Publicado: (2022)

The Association Between High CHA(2)DS(2)-VASc Scores and Short and Long-Term Mortality for Coronary Care Unit Patients
por: Cheng, Long, et al.
Publicado: (2022)

Left atrial spontaneous echo contrast occurring in patients with low CHADS(2) or CHA(2)DS(2)-VASc scores
por: Akamatsu, Kanako, et al.
Publicado: (2020)

New CHA(2)DS(2)-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
por: Zhang, Qin-Yao, et al.
Publicado: (2020)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Applying the CHA(2)DS(2)-VASc score to predict the risk of future acute coronary syndrome in patients receiving catheter ablation for atrial fibrillation
por: Chou, Ching-Yao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_716h516a17l6qslaa1dg0bqfud